CoChat
Sign Up
Cited by 29

The DOI matches its Crossref record; 5 of the 5 references it cites were found in a registry or an index.

Regulation of the alternative β-secretase meprin β by ADAM-mediated shedding

Scharfenberg, Franka, Armbrust, Fred, Marengo, Liana, Pietrzik, Claus, Becker-Pauly, Christoph·2019·Cellular and Molecular Life Sciences
DOI 10.1007/s00018-019-03179-1
Open this paper in CoChat — free account

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1007/s00018-019-03179-1

Cites

5 of 5 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Flagged first, then by citations

Research works printed but not linked: 118

  1. Broder C, Becker-Pauly C (2013) The metalloproteases meprin alpha and meprin beta: unique enzymes in inflammation, neurodegeneration, cancer and fibrosis. Biochem J 450(2):253–264. https://doi.org/10.1042/BJ20121751 · DOI
  2. Bode W, Grams F, Reinemer P, Gomis-Ruth FX, Baumann U, McKay DB, Stocker W (1996) The metzincin-superfamily of zinc-peptidases. Adv Exp Med Biol 389:1–11 · DOI
  3. Gomis-Ruth FX (2003) Structural aspects of the metzincin clan of metalloendopeptidases. Mol Biotechnol 24(2):157–202. https://doi.org/10.1385/MB:24:2:157 · DOI
  4. Gomis-Ruth FX, Trillo-Muyo S, Stocker W (2012) Functional and structural insights into astacin metallopeptidases. Biol Chem 393(10):1027–1041. https://doi.org/10.1515/hsz-2012-0149 · DOI
  5. Becker-Pauly C, Barre O, Schilling O, Auf dem Keller U, Ohler A, Broder C, Schutte A, Kappelhoff R, Stocker W, Overall CM (2011) Proteomic analyses reveal an acidic prime side specificity for the astacin metalloprotease family reflected by physiological substrates. Mol Cell Proteomics 10(9):M111009233. https://doi.org/10.1074/mcp.m111.009233 · DOI
  6. Arnold P, Otte A (1864) Becker-Pauly C (2017) Meprin metalloproteases: molecular regulation and function in inflammation and fibrosis. Biochim Biophys Acta Mol Cell Res 11 Pt B:2096–2104. https://doi.org/10.1016/j.bbamcr.2017.05.011 · DOI
  7. Becker-Pauly C, Pietrzik CU (2016) The metalloprotease meprin beta is an alternative beta-secretase of APP. Front Mol Neurosci 9:159. https://doi.org/10.3389/fnmol.2016.00159 · DOI
  8. Arnold P, Boll I, Rothaug M, Schumacher N, Schmidt F, Wichert R, Schneppenheim J, Lokau J, Pickhinke U, Koudelka T, Tholey A, Rabe B, Scheller J, Lucius R, Garbers C, Rose-John S, Becker-Pauly C (2017) Meprin metalloproteases generate biologically active soluble interleukin-6 receptor to induce trans-signaling. Sci Rep 7:44053. https://doi.org/10.1038/srep44053 · DOI
  9. Banerjee S, Jin G, Bradley SG, Matters GL, Gailey RD, Crisman JM, Bond JS (2011) Balance of meprin A and B in mice affects the progression of experimental inflammatory bowel disease. Am J Physiol Gastrointest Liver Physiol 300(2):G273–G282. https://doi.org/10.1152/ajpgi.00504.2009 · DOI
  10. Keiffer TR, Bond JS (2014) Meprin metalloproteases inactivate interleukin 6. J Biol Chem 289(11):7580–7588. https://doi.org/10.1074/jbc.M113.546309 · DOI
  11. Oneda B, Lods N, Lottaz D, Becker-Pauly C, Stocker W, Pippin J, Huguenin M, Ambort D, Marti HP, Sterchi EE (2008) Metalloprotease meprin beta in rat kidney: glomerular localization and differential expression in glomerulonephritis. PLoS One 3(5):e2278. https://doi.org/10.1371/journal.pone.0002278 · DOI
  12. Bylander JE, Ahmed F, Conley SM, Mwiza JM, Ongeri EM (2017) Meprin metalloprotease deficiency associated with higher mortality rates and more severe diabetic kidney injury in mice with STZ-induced type 1 diabetes. J Diabetes Res 2017:9035038. https://doi.org/10.1155/2017/9035038 · DOI
  13. Alidori S, Akhavein N, Thorek DL, Behling K, Romin Y, Queen D, Beattie BJ, Manova-Todorova K, Bergkvist M, Scheinberg DA, McDevitt MR (2016) Targeted fibrillar nanocarbon RNAi treatment of acute kidney injury. Sci Transl Med 8(331):331ra339. https://doi.org/10.1126/scitranslmed.aac9647 · DOI
  14. Bedau T, Peters F, Prox J, Arnold P, Schmidt F, Finkernagel M, Kollmann S, Wichert R, Otte A, Ohler A, Stirnberg M, Lucius R, Koudelka T, Tholey A, Biasin V, Pietrzik CU, Kwapiszewska G, Becker-Pauly C (2017) Ectodomain shedding of CD99 within highly conserved regions is mediated by the metalloprotease meprin beta and promotes transendothelial cell migration. FASEB J 31(3):1226–1237. https://doi.org/10.1096/fj.201601113R · DOI
  15. Bedau T, Schumacher N, Peters F, Prox J, Arnold P, Koudelka T, Helm O, Schmidt F, Rabe B, Jentzsch M, Rosenstiel P, Sebens S, Tholey A, Rose-John S, Becker-Pauly C (2017) Cancer-associated mutations in the canonical cleavage site do not influence CD99 shedding by the metalloprotease meprin beta but alter cell migration in vitro. Oncotarget 8(33):54873–54888. https://doi.org/10.18632/oncotarget.18966 · DOI
  16. Kruse MN, Becker C, Lottaz D, Kohler D, Yiallouros I, Krell HW, Sterchi EE, Stocker W (2004) Human meprin alpha and beta homo-oligomers: cleavage of basement membrane proteins and sensitivity to metalloprotease inhibitors. Biochem J 378(Pt 2):383–389. https://doi.org/10.1042/BJ20031163 · DOI
  17. Broder C, Arnold P, Vadon-Le Goff S, Konerding MA, Bahr K, Muller S, Overall CM, Bond JS, Koudelka T, Tholey A, Hulmes DJ, Moali C, Becker-Pauly C (2013) Metalloproteases meprin alpha and meprin beta are C- and N-procollagen proteinases important for collagen assembly and tensile strength. Proc Natl Acad Sci USA 110(35):14219–14224. https://doi.org/10.1073/pnas.1305464110 · DOI
  18. Kronenberg D, Bruns BC, Moali C, Vadon-Le Goff S, Sterchi EE, Traupe H, Bohm M, Hulmes DJ, Stocker W, Becker-Pauly C (2010) Processing of procollagen III by meprins: new players in extracellular matrix assembly? J Invest Dermatol 130(12):2727–2735. https://doi.org/10.1038/jid.2010.202 · DOI
  19. Schutte A, Ermund A, Becker-Pauly C, Johansson ME, Rodriguez-Pineiro AM, Backhed F, Muller S, Lottaz D, Bond JS, Hansson GC (2014) Microbial-induced meprin beta cleavage in MUC2 mucin and a functional CFTR channel are required to release anchored small intestinal mucus. Proc Natl Acad Sci USA 111(34):12396–12401. https://doi.org/10.1073/pnas.1407597111 · DOI
  20. Johansson ME, Hansson GC (2016) Immunological aspects of intestinal mucus and mucins. Nat Rev Immunol 16(10):639–649. https://doi.org/10.1038/nri.2016.88 · DOI · Paper page
  21. Wichert R, Ermund A, Schmidt S, Schweinlin M, Ksiazek M, Arnold P, Knittler K, Wilkens F, Potempa B, Rabe B, Stirnberg M, Lucius R, Bartsch JW, Nikolaus S, Falk-Paulsen M, Rosenstiel P, Metzger M, Rose-John S, Potempa J, Hansson GC, Dempsey PJ, Becker-Pauly C (2017) Mucus detachment by host metalloprotease meprin beta requires shedding of its inactive Pro-form, which is abrogated by the pathogenic protease RgpB. Cell Rep 21(8):2090–2103. https://doi.org/10.1016/j.celrep.2017.10.087 · DOI
  22. Jackle F, Schmidt F, Wichert R, Arnold P, Prox J, Mangold M, Ohler A, Pietrzik CU, Koudelka T, Tholey A, Gutschow M, Stirnberg M, Becker-Pauly C (2015) Metalloprotease meprin beta is activated by transmembrane serine protease matriptase-2 at the cell surface thereby enhancing APP shedding. Biochem J 470(1):91–103. https://doi.org/10.1042/BJ20141417 · DOI
  23. Bien J, Jefferson T, Causevic M, Jumpertz T, Munter L, Multhaup G, Weggen S, Becker-Pauly C, Pietrzik CU (2012) The metalloprotease meprin beta generates amino terminal-truncated amyloid beta peptide species. J Biol Chem 287(40):33304–33313. https://doi.org/10.1074/jbc.M112.395608 · DOI · Paper page
  24. Moller HJ, Graeber MB (1998) The case described by Alois Alzheimer in 1911. Historical and conceptual perspectives based on the clinical record and neurohistological sections. Eur Arch Psychiatry Clin Neurosci 248(3):111–122 · DOI
  25. Murphy MP, LeVine H 3rd (2010) Alzheimer’s disease and the amyloid-beta peptide. J Alzheimers Dis 19(1):311–323. https://doi.org/10.3233/JAD-2010-1221 · DOI · Paper page
  26. Sengupta U, Nilson AN, Kayed R (2016) The role of amyloid-beta oligomers in toxicity, propagation, and immunotherapy. EBioMedicine 6:42–49. https://doi.org/10.1016/j.ebiom.2016.03.035 · DOI · Paper page
  27. Mark RJ, Lovell MA, Markesbery WR, Uchida K, Mattson MP (1997) A role for 4-hydroxynonenal, an aldehydic product of lipid peroxidation, in disruption of ion homeostasis and neuronal death induced by amyloid beta-peptide. J Neurochem 68(1):255–264 · DOI
  28. Abramov AY, Canevari L, Duchen MR (2004) Calcium signals induced by amyloid beta peptide and their consequences in neurons and astrocytes in culture. Biochim Biophys Acta 1742(1–3):81–87. https://doi.org/10.1016/j.bbamcr.2004.09.006 · DOI · Paper page
  29. McLaurin J, Chakrabartty A (1996) Membrane disruption by Alzheimer beta-amyloid peptides mediated through specific binding to either phospholipids or gangliosides. Implications for neurotoxicity. J Biol Chem 271(43):26482–26489 · DOI
  30. Venugopal C, Demos CM, Rao KS, Pappolla MA, Sambamurti K (2008) Beta-secretase: structure, function, and evolution. CNS Neurol Disord Drug Targets 7(3):278–294 · DOI
  31. Bohm C, Chen F, Sevalle J, Qamar S, Dodd R, Li Y, Schmitt-Ulms G, Fraser PE, St George-Hyslop PH (2015) Current and future implications of basic and translational research on amyloid-beta peptide production and removal pathways. Mol Cell Neurosci 66(Pt A):3–11. https://doi.org/10.1016/j.mcn.2015.02.016 · DOI
  32. Bitan G, Kirkitadze MD, Lomakin A, Vollers SS, Benedek GB, Teplow DB (2003) Amyloid beta -protein (Abeta) assembly: abeta 40 and Abeta 42 oligomerize through distinct pathways. Proc Natl Acad Sci USA 100(1):330–335. https://doi.org/10.1073/pnas.222681699 · DOI
  33. Beglopoulos V, Sun X, Saura CA, Lemere CA, Kim RD, Shen J (2004) Reduced beta-amyloid production and increased inflammatory responses in presenilin conditional knock-out mice. J Biol Chem 279(45):46907–46914. https://doi.org/10.1074/jbc.M409544200 · DOI
  34. Sun L, Zhou R, Yang G, Shi Y (2017) Analysis of 138 pathogenic mutations in presenilin-1 on the in vitro production of Abeta42 and Abeta40 peptides by gamma-secretase. Proc Natl Acad Sci USA 114(4):E476–E485. https://doi.org/10.1073/pnas.1618657114 · DOI · Paper page
  35. Luo Y, Bolon B, Kahn S, Bennett BD, Babu-Khan S, Denis P, Fan W, Kha H, Zhang J, Gong Y, Martin L, Louis JC, Yan Q, Richards WG, Citron M, Vassar R (2001) Mice deficient in BACE1, the Alzheimer’s beta-secretase, have normal phenotype and abolished beta-amyloid generation. Nat Neurosci 4(3):231–232. https://doi.org/10.1038/85059 · DOI · Paper page
  36. Cai H, Wang Y, McCarthy D, Wen H, Borchelt DR, Price DL, Wong PC (2001) BACE1 is the major beta-secretase for generation of Abeta peptides by neurons. Nat Neurosci 4(3):233–234. https://doi.org/10.1038/85064 · DOI
  37. Vassar R, Bennett BD, Babu-Khan S, Kahn S, Mendiaz EA, Denis P, Teplow DB, Ross S, Amarante P, Loeloff R, Luo Y, Fisher S, Fuller J, Edenson S, Lile J, Jarosinski MA, Biere AL, Curran E, Burgess T, Louis JC, Collins F, Treanor J, Rogers G, Citron M (1999) Beta-secretase cleavage of Alzheimer’s amyloid precursor protein by the transmembrane aspartic protease BACE. Science 286(5440):735–741 · DOI · Paper page
  38. Vassar R (2002) Beta-secretase (BACE) as a drug target for Alzheimer’s disease. Adv Drug Deliv Rev 54(12):1589–1602 · DOI
  39. Nishitomi K, Sakaguchi G, Horikoshi Y, Gray AJ, Maeda M, Hirata-Fukae C, Becker AG, Hosono M, Sakaguchi I, Minami SS, Nakajima Y, Li HF, Takeyama C, Kihara T, Ota A, Wong PC, Aisen PS, Kato A, Kinoshita N, Matsuoka Y (2006) BACE1 inhibition reduces endogenous Abeta and alters APP processing in wild-type mice. J Neurochem 99(6):1555–1563. https://doi.org/10.1111/j.1471-4159.2006.04178.x · DOI
  40. Masters CL, Simms G, Weinman NA, Multhaup G, McDonald BL, Beyreuther K (1985) Amyloid plaque core protein in Alzheimer disease and Down syndrome. Proc Natl Acad Sci USA 82(12):4245–4249 · DOI · Paper page
  41. Wiltfang J, Esselmann H, Cupers P, Neumann M, Kretzschmar H, Beyermann M, Schleuder D, Jahn H, Ruther E, Kornhuber J, Annaert W, De Strooper B, Saftig P (2001) Elevation of beta-amyloid peptide 2-42 in sporadic and familial Alzheimer’s disease and its generation in PS1 knockout cells. J Biol Chem 276(46):42645–42657. https://doi.org/10.1074/jbc.M102790200 · DOI
  42. Kummer MP, Heneka MT (2014) Truncated and modified amyloid-beta species. Alzheimers Res Ther 6(3):28. https://doi.org/10.1186/alzrt258 · DOI
  43. Bibl M, Gallus M, Welge V, Esselmann H, Wiltfang J (2012) Aminoterminally truncated and oxidized amyloid-beta peptides in the cerebrospinal fluid of Alzheimer’s disease patients. J Alzheimers Dis 29(4):809–816. https://doi.org/10.3233/JAD-2012-111796 · DOI
  44. Schechter I, Ziv E (2011) Cathepsins S, B and L with aminopeptidases display beta-secretase activity associated with the pathogenesis of Alzheimer’s disease. Biol Chem 392(6):555–569. https://doi.org/10.1515/BC.2011.054 · DOI
  45. Hook G, Yu J, Toneff T, Kindy M, Hook V (2014) Brain pyroglutamate amyloid-beta is produced by cathepsin B and is reduced by the cysteine protease inhibitor E64d, representing a potential Alzheimer’s disease therapeutic. J Alzheimers Dis 41(1):129–149. https://doi.org/10.3233/JAD-131370 · DOI
  46. Munger JS, Haass C, Lemere CA, Shi GP, Wong WS, Teplow DB, Selkoe DJ, Chapman HA (1995) Lysosomal processing of amyloid precursor protein to A beta peptides: a distinct role for cathepsin S. Biochem J 311(Pt 1):299–305 · DOI
  47. Hamazaki H (1996) Cathepsin D is involved in the clearance of Alzheimer’s beta-amyloid protein. FEBS Lett 396(2–3):139–142 · DOI · Paper page
  48. Mueller-Steiner S, Zhou Y, Arai H, Roberson ED, Sun B, Chen J, Wang X, Yu G, Esposito L, Mucke L, Gan L (2006) Antiamyloidogenic and neuroprotective functions of cathepsin B: implications for Alzheimer’s disease. Neuron 51(6):703–714. https://doi.org/10.1016/j.neuron.2006.07.027 · DOI
  49. Letronne F, Laumet G, Ayral AM, Chapuis J, Demiautte F, Laga M, Vandenberghe ME, Malmanche N, Leroux F, Eysert F, Sottejeau Y, Chami L, Flaig A, Bauer C, Dourlen P, Lesaffre M, Delay C, Huot L, Dumont J, Werkmeister E, Lafont F, Mendes T, Hansmannel F, Dermaut B, Deprez B, Herard AS, Dhenain M, Souedet N, Pasquier F, Tulasne D, Berr C, Hauw JJ, Lemoine Y, Amouyel P, Mann D, Deprez R, Checler F, Hot D, Delzescaux T, Gevaert K, Lambert JC (2016) ADAM30 downregulates APP-Linked defects through cathepsin D activation in Alzheimer’s disease. EBioMedicine 9:278–292. https://doi.org/10.1016/j.ebiom.2016.06.002 · DOI
  50. Sevalle J, Amoyel A, Robert P, Fournie-Zaluski MC, Roques B, Checler F (2009) Aminopeptidase A contributes to the N-terminal truncation of amyloid beta-peptide. J Neurochem 109(1):248–256. https://doi.org/10.1111/j.1471-4159.2009.05950.x · DOI
  51. Schlenzig D, Cynis H, Hartlage-Rubsamen M, Zeitschel U, Menge K, Fothe A, Ramsbeck D, Spahn C, Wermann M, Rossner S, Buchholz M, Schilling S, Demuth HU (2018) Dipeptidyl-peptidase activity of meprin beta links N-truncation of abeta with glutaminyl cyclase-catalyzed pGlu-abeta formation. J Alzheimers Dis 66(1):359–375. https://doi.org/10.3233/JAD-171183 · DOI · Paper page
  52. Schonherr C, Bien J, Isbert S, Wichert R, Prox J, Altmeppen H, Kumar S, Walter J, Lichtenthaler SF, Weggen S, Glatzel M, Becker-Pauly C, Pietrzik CU (2016) Generation of aggregation prone N-terminally truncated amyloid beta peptides by meprin beta depends on the sequence specificity at the cleavage site. Mol Neurodegener 11:19. https://doi.org/10.1186/s13024-016-0084-5 · DOI · Paper page
  53. Jefferson T, Causevic M, Auf dem Keller U, Schilling O, Isbert S, Geyer R, Maier W, Tschickardt S, Jumpertz T, Weggen S, Bond JS, Overall CM, Pietrzik CU, Becker-Pauly C (2011) Metalloprotease meprin beta generates nontoxic N-terminal amyloid precursor protein fragments in vivo. J Biol Chem 286(31):27741–27750. https://doi.org/10.1074/jbc.M111.252718 · DOI · Paper page
  54. Elder GA, Gama Sosa MA, De Gasperi R (2010) Transgenic mouse models of Alzheimer’s disease. Mt Sinai J Med 77(1):69–81. https://doi.org/10.1002/msj.20159 · DOI · Paper page
  55. Ohshima Y, Taguchi K, Mizuta I, Tanaka M, Tomiyama T, Kametani F, Yabe-Nishimura C, Mizuno T, Tokuda T (2018) Mutations in the beta-amyloid precursor protein in familial Alzheimer’s disease increase Abeta oligomer production in cellular models. Heliyon 4(1):e00511. https://doi.org/10.1016/j.heliyon.2018.e00511 · DOI
  56. Ohno M, Sametsky EA, Younkin LH, Oakley H, Younkin SG, Citron M, Vassar R, Disterhoft JF (2004) BACE1 deficiency rescues memory deficits and cholinergic dysfunction in a mouse model of Alzheimer’s disease. Neuron 41(1):27–33 · DOI · Paper page
  57. Patel T, Brookes KJ, Turton J, Chaudhury S, Guetta-Baranes T, Guerreiro R, Bras J, Hernandez D, Singleton A, Francis PT, Hardy J, Morgan K (2017) Whole-exome sequencing of the BDR cohort: evidence to support the role of the PILRA gene in Alzheimer’s disease. Neuropathol Appl Neurobiol 44:506–521. https://doi.org/10.1111/nan.12452 · DOI
  58. Ohler A, Debela M, Wagner S, Magdolen V, Becker-Pauly C (2010) Analyzing the protease web in skin: meprin metalloproteases are activated specifically by KLK4, 5 and 8 vice versa leading to processing of proKLK7 thereby triggering its activation. Biol Chem 391(4):455–460. https://doi.org/10.1515/BC.2010.023 · DOI
  59. Jefferson T, Auf dem Keller U, Bellac C, Metz VV, Broder C, Hedrich J, Ohler A, Maier W, Magdolen V, Sterchi E, Bond JS, Jayakumar A, Traupe H, Chalaris A, Rose-John S, Pietrzik CU, Postina R, Overall CM, Becker-Pauly C (2013) The substrate degradome of meprin metalloproteases reveals an unexpected proteolytic link between meprin beta and ADAM10. Cell Mol Life Sci 70(2):309–333. https://doi.org/10.1007/s00018-012-1106-2 · DOI
  60. Herzog C, Haun RS, Ludwig A, Shah SV, Kaushal GP (2014) ADAM10 is the major sheddase responsible for the release of membrane-associated meprin A. J Biol Chem 289(19):13308–13322. https://doi.org/10.1074/jbc.M114.559088 · DOI
  61. Banerjee S, Bond JS (2008) Prointerleukin-18 is activated by meprin beta in vitro and in vivo in intestinal inflammation. J Biol Chem 283(46):31371–31377. https://doi.org/10.1074/jbc.M802814200 · DOI
  62. Nikolaev A, McLaughlin T, O’Leary DD, Tessier-Lavigne M (2009) APP binds DR6 to trigger axon pruning and neuron death via distinct caspases. Nature 457(7232):981–989. https://doi.org/10.1038/nature07767 · DOI · Paper page
  63. Olsen O, Kallop DY, McLaughlin T, Huntwork-Rodriguez S, Wu Z, Duggan CD, Simon DJ, Lu Y, Easley-Neal C, Takeda K, Hass PE, Jaworski A, O’Leary DD, Weimer RM, Tessier-Lavigne M (2014) Genetic analysis reveals that amyloid precursor protein and death receptor 6 function in the same pathway to control axonal pruning independent of beta-secretase. J Neurosci 34(19):6438–6447. https://doi.org/10.1523/JNEUROSCI.3522-13.2014 · DOI · Paper page
  64. Peron R, Vatanabe IP, Manzine PR, Camins A, Cominetti MR (2018) Alpha-secretase ADAM10 regulation: insights into Alzheimer’s disease Treatment. Pharmaceuticals 11:1. https://doi.org/10.3390/ph11010012 · DOI
  65. Wasco W, Bupp K, Magendantz M, Gusella JF, Tanzi RE, Solomon F (1992) Identification of a mouse brain cDNA that encodes a protein related to the Alzheimer disease-associated amyloid beta protein precursor. Proc Natl Acad Sci USA 89(22):10758–10762 · DOI
  66. Pandey P, Sliker B, Peters HL, Tuli A, Herskovitz J, Smits K, Purohit A, Singh RK, Dong J, Batra SK, Coulter DW, Solheim JC (2016) Amyloid precursor protein and amyloid precursor-like protein 2 in cancer. Oncotarget 7(15):19430–19444. https://doi.org/10.18632/oncotarget.7103 · DOI
  67. Jacobsen KT, Iverfeldt K (2009) Amyloid precursor protein and its homologues: a family of proteolysis-dependent receptors. Cell Mol Life Sci 66(14):2299–2318. https://doi.org/10.1007/s00018-009-0020-8 · DOI
  68. Sprecher CA, Grant FJ, Grimm G, O’Hara PJ, Norris F, Norris K, Foster DC (1993) Molecular cloning of the cDNA for a human amyloid precursor protein homolog: evidence for a multigene family. Biochemistry 32(17):4481–4486 · DOI
  69. Wasco W, Gurubhagavatula S, Paradis MD, Romano DM, Sisodia SS, Hyman BT, Neve RL, Tanzi RE (1993) Isolation and characterization of APLP2 encoding a homologue of the Alzheimer’s associated amyloid beta protein precursor. Nat Genet 5(1):95–100. https://doi.org/10.1038/ng0993-95 · DOI
  70. Coulson EJ, Paliga K, Beyreuther K, Masters CL (2000) What the evolution of the amyloid protein precursor supergene family tells us about its function. Neurochem Int 36(3):175–184 · DOI
  71. Rossjohn J, Cappai R, Feil SC, Henry A, McKinstry WJ, Galatis D, Hesse L, Multhaup G, Beyreuther K, Masters CL, Parker MW (1999) Crystal structure of the N-terminal, growth factor-like domain of Alzheimer amyloid precursor protein. Nat Struct Biol 6(4):327–331. https://doi.org/10.1038/7562 · DOI
  72. Barnham KJ, McKinstry WJ, Multhaup G, Galatis D, Morton CJ, Curtain CC, Williamson NA, White AR, Hinds MG, Norton RS, Beyreuther K, Masters CL, Parker MW, Cappai R (2003) Structure of the Alzheimer’s disease amyloid precursor protein copper binding domain. A regulator of neuronal copper homeostasis. J Biol Chem 278(19):17401–17407. https://doi.org/10.1074/jbc.m300629200 · DOI
  73. Kong GK, Adams JJ, Harris HH, Boas JF, Curtain CC, Galatis D, Masters CL, Barnham KJ, McKinstry WJ, Cappai R, Parker MW (2007) Structural studies of the Alzheimer’s amyloid precursor protein copper-binding domain reveal how it binds copper ions. J Mol Biol 367(1):148–161. https://doi.org/10.1016/j.jmb.2006.12.041 · DOI
  74. Dahms SO, Hoefgen S, Roeser D, Schlott B, Guhrs KH, Than ME (2010) Structure and biochemical analysis of the heparin-induced E1 dimer of the amyloid precursor protein. Proc Natl Acad Sci USA 107(12):5381–5386. https://doi.org/10.1073/pnas.0911326107 · DOI
  75. Kang J, Muller-Hill B (1990) Differential splicing of Alzheimer’s disease amyloid A4 precursor RNA in rat tissues: pre A4(695) mRNA is predominantly produced in rat and human brain. Biochem Biophys Res Commun 166(3):1192–1200 · DOI
  76. Weidemann A, Konig G, Bunke D, Fischer P, Salbaum JM, Masters CL, Beyreuther K (1989) Identification, biogenesis, and localization of precursors of Alzheimer’s disease A4 amyloid protein. Cell 57(1):115–126 · DOI
  77. Ninomiya H, Roch JM, Sundsmo MP, Otero DA, Saitoh T (1993) Amino acid sequence RERMS represents the active domain of amyloid beta/A4 protein precursor that promotes fibroblast growth. J Cell Biol 121(4):879–886 · DOI
  78. Ninomiya H, Roch JM, Jin LW, Saitoh T (1994) Secreted form of amyloid beta/A4 protein precursor (APP) binds to two distinct APP binding sites on rat B103 neuron-like cells through two different domains, but only one site is involved in neuritotropic activity. J Neurochem 63(2):495–500 · DOI
  79. Pawlik M, Otero DA, Park M, Fischer WH, Levy E, Saitoh T (2007) Proteins that bind to the RERMS region of beta amyloid precursor protein. Biochem Biophys Res Commun 355(4):907–912. https://doi.org/10.1016/j.bbrc.2007.02.047 · DOI
  80. Gralle M, Ferreira ST (2007) Structure and functions of the human amyloid precursor protein: the whole is more than the sum of its parts. Prog Neurobiol 82(1):11–32. https://doi.org/10.1016/j.pneurobio.2007.02.001 · DOI
  81. Reinhard C, Hebert SS, De Strooper B (2005) The amyloid-beta precursor protein: integrating structure with biological function. EMBO J 24(23):3996–4006. https://doi.org/10.1038/sj.emboj.7600860 · DOI
  82. Turner PR, O’Connor K, Tate WP, Abraham WC (2003) Roles of amyloid precursor protein and its fragments in regulating neural activity, plasticity and memory. Prog Neurobiol 70(1):1–32 · DOI
  83. Wang Y, Ha Y (2004) The X-ray structure of an antiparallel dimer of the human amyloid precursor protein E2 domain. Mol Cell 15(3):343–353. https://doi.org/10.1016/j.molcel.2004.06.037 · DOI
  84. Pahlsson P, Shakin-Eshleman SH, Spitalnik SL (1992) N-linked glycosylation of beta-amyloid precursor protein. Biochem Biophys Res Commun 189(3):1667–1673 · DOI
  85. Hoefgen S, Dahms SO, Oertwig K, Than ME (2015) The amyloid precursor protein shows a pH-dependent conformational switch in its E1 domain. J Mol Biol 427(2):433–442. https://doi.org/10.1016/j.jmb.2014.12.005 · DOI
  86. Hoefgen S, Coburger I, Roeser D, Schaub Y, Dahms SO, Than ME (2014) Heparin induced dimerization of APP is primarily mediated by E1 and regulated by its acidic domain. J Struct Biol 187(1):30–37. https://doi.org/10.1016/j.jsb.2014.05.006 · DOI
  87. Dahms SO, Konnig I, Roeser D, Guhrs KH, Mayer MC, Kaden D, Multhaup G, Than ME (2012) Metal binding dictates conformation and function of the amyloid precursor protein (APP) E2 domain. J Mol Biol 416(3):438–452. https://doi.org/10.1016/j.jmb.2011.12.057 · DOI
  88. Keil C, Huber R, Bode W, Than ME (2004) Cloning, expression, crystallization and initial crystallographic analysis of the C-terminal domain of the amyloid precursor protein APP. Acta Crystallogr D Biol Crystallogr 60(Pt 9):1614–1617. https://doi.org/10.1107/S0907444904015343 · DOI
  89. Dulubova I, Ho A, Huryeva I, Sudhof TC, Rizo J (2004) Three-dimensional structure of an independently folded extracellular domain of human amyloid-beta precursor protein. Biochemistry 43(30):9583–9588. https://doi.org/10.1021/bi049041o · DOI
  90. Lu JX, Yau WM, Tycko R (2011) Evidence from solid-state NMR for nonhelical conformations in the transmembrane domain of the amyloid precursor protein. Biophys J 100(3):711–719. https://doi.org/10.1016/j.bpj.2010.12.3696 · DOI
  91. Botev A, Munter LM, Wenzel R, Richter L, Althoff V, Ismer J, Gerling U, Weise C, Koksch B, Hildebrand PW, Bittl R, Multhaup G (2011) The amyloid precursor protein C-terminal fragment C100 occurs in monomeric and dimeric stable conformations and binds gamma-secretase modulators. Biochemistry 50(5):828–835. https://doi.org/10.1021/bi1014002 · DOI
  92. Nadezhdin KD, Bocharova OV, Bocharov EV, Arseniev AS (2011) Structural and dynamic study of the transmembrane domain of the amyloid precursor protein. Acta Naturae 3(1):69–76 · DOI
  93. Beel AJ, Mobley CK, Kim HJ, Tian F, Hadziselimovic A, Jap B, Prestegard JH, Sanders CR (2008) Structural studies of the transmembrane C-terminal domain of the amyloid precursor protein (APP): does APP function as a cholesterol sensor? Biochemistry 47(36):9428–9446. https://doi.org/10.1021/bi800993c · DOI
  94. Sato T, Tang TC, Reubins G, Fei JZ, Fujimoto T, Kienlen-Campard P, Constantinescu SN, Octave JN, Aimoto S, Smith SO (2009) A helix-to-coil transition at the epsilon-cut site in the transmembrane dimer of the amyloid precursor protein is required for proteolysis. Proc Natl Acad Sci USA 106(5):1421–1426. https://doi.org/10.1073/pnas.0812261106 · DOI
  95. Barrett PJ, Song Y, Van Horn WD, Hustedt EJ, Schafer JM, Hadziselimovic A, Beel AJ, Sanders CR (2012) The amyloid precursor protein has a flexible transmembrane domain and binds cholesterol. Science 336(6085):1168–1171. https://doi.org/10.1126/science.1219988 · DOI · Paper page
  96. MacKenzie KR, Prestegard JH, Engelman DM (1997) A transmembrane helix dimer: structure and implications. Science 276(5309):131–133 · DOI
  97. Javadpour MM, Eilers M, Groesbeek M, Smith SO (1999) Helix packing in polytopic membrane proteins: role of glycine in transmembrane helix association. Biophys J 77(3):1609–1618. https://doi.org/10.1016/S0006-3495(99)77009-8 · DOI
  98. Kim S, Jeon TJ, Oberai A, Yang D, Schmidt JJ, Bowie JU (2005) Transmembrane glycine zippers: physiological and pathological roles in membrane proteins. Proc Natl Acad Sci USA 102(40):14278–14283. https://doi.org/10.1073/pnas.0501234102 · DOI
  99. Anderson SM, Mueller BK, Lange EJ, Senes A (2017) Combination of Calpha-H Hydrogen Bonds and van der Waals Packing Modulates the Stability of GxxxG-Mediated Dimers in Membranes. J Am Chem Soc 139(44):15774–15783. https://doi.org/10.1021/jacs.7b07505 · DOI
  100. Munter LM, Voigt P, Harmeier A, Kaden D, Gottschalk KE, Weise C, Pipkorn R, Schaefer M, Langosch D, Multhaup G (2007) GxxxG motifs within the amyloid precursor protein transmembrane sequence are critical for the etiology of Abeta42. EMBO J 26(6):1702–1712. https://doi.org/10.1038/sj.emboj.7601616 · DOI
  101. Decock M, Stanga S, Octave JN, Dewachter I, Smith SO, Constantinescu SN, Kienlen-Campard P (2016) Glycines from the APP GXXXG/GXXXA transmembrane motifs promote formation of pathogenic abeta oligomers in cells. Front Aging Neurosci 8:107. https://doi.org/10.3389/fnagi.2016.00107 · DOI
  102. Yano Y, Kondo K, Watanabe Y, Zhang TO, Ho JJ, Oishi S, Fujii N, Zanni MT, Matsuzaki K (2017) GXXXG-Mediated Parallel and Antiparallel Dimerization of Transmembrane Helices and Its Inhibition by Cholesterol: single-Pair FRET and 2D IR Studies. Angew Chem Int Ed Engl 56(7):1756–1759. https://doi.org/10.1002/anie.201609708 · DOI
  103. Yan Y, Xu TH, Harikumar KG, Miller LJ, Melcher K, Xu HE (2017) Dimerization of the transmembrane domain of amyloid precursor protein is determined by residues around the gamma-secretase cleavage sites. J Biol Chem 292(38):15826–15837. https://doi.org/10.1074/jbc.M117.789669 · DOI
  104. Nadezhdin KD, Bocharova OV, Bocharov EV, Arseniev AS (2012) Dimeric structure of transmembrane domain of amyloid precursor protein in micellar environment. FEBS Lett 586(12):1687–1692. https://doi.org/10.1016/j.febslet.2012.04.062 · DOI
  105. Chen W, Gamache E, Rosenman DJ, Xie J, Lopez MM, Li YM, Wang C (2014) Familial Alzheimer’s mutations within APPTM increase Abeta42 production by enhancing accessibility of epsilon-cleavage site. Nat Commun 5:3037. https://doi.org/10.1038/ncomms4037 · DOI
  106. Song Y, Hustedt EJ, Brandon S, Sanders CR (2013) Competition between homodimerization and cholesterol binding to the C99 domain of the amyloid precursor protein. Biochemistry 52(30):5051–5064. https://doi.org/10.1021/bi400735x · DOI
  107. Dominguez L, Foster L, Straub JE, Thirumalai D (2016) Impact of membrane lipid composition on the structure and stability of the transmembrane domain of amyloid precursor protein. Proc Natl Acad Sci USA 113(36):E5281–5287. https://doi.org/10.1073/pnas.1606482113 · DOI
  108. Dominguez L, Foster L, Meredith SC, Straub JE, Thirumalai D (2014) Structural heterogeneity in transmembrane amyloid precursor protein homodimer is a consequence of environmental selection. J Am Chem Soc 136(27):9619–9626. https://doi.org/10.1021/ja503150x · DOI
  109. Pantelopulos GA, Straub JE, Thirumalai D, Sugita Y (2018) Structure of APP-C991-99 and implications for role of extra-membrane domains in function and oligomerization. Biochim Biophys Acta Biomembr 1860:1698–1708. https://doi.org/10.1016/j.bbamem.2018.04.002 · DOI
  110. Ramelot TA, Gentile LN, Nicholson LK (2000) Transient structure of the amyloid precursor protein cytoplasmic tail indicates preordering of structure for binding to cytosolic factors. Biochemistry 39(10):2714–2725 · DOI
  111. Ando K, Iijima KI, Elliott JI, Kirino Y, Suzuki T (2001) Phosphorylation-dependent regulation of the interaction of amyloid precursor protein with Fe65 affects the production of beta-amyloid. J Biol Chem 276(43):40353–40361. https://doi.org/10.1074/jbc.M104059200 · DOI
  112. Yun M, Keshvara L, Park CG, Zhang YM, Dickerson JB, Zheng J, Rock CO, Curran T, Park HW (2003) Crystal structures of the Dab homology domains of mouse disabled 1 and 2. J Biol Chem 278(38):36572–36581. https://doi.org/10.1074/jbc.M304384200 · DOI
  113. Zhang Z, Lee CH, Mandiyan V, Borg JP, Margolis B, Schlessinger J, Kuriyan J (1997) Sequence-specific recognition of the internalization motif of the Alzheimer’s amyloid precursor protein by the X11 PTB domain. EMBO J 16(20):6141–6150. https://doi.org/10.1093/emboj/16.20.6141 · DOI · Paper page
  114. Radzimanowski J, Simon B, Sattler M, Beyreuther K, Sinning I, Wild K (2008) Structure of the intracellular domain of the amyloid precursor protein in complex with Fe65-PTB2. EMBO Rep 9(11):1134–1140. https://doi.org/10.1038/embor.2008.188 · DOI
  115. Arolas JL, Broder C, Jefferson T, Guevara T, Sterchi EE, Bode W, Stocker W, Becker-Pauly C, Gomis-Ruth FX (2012) Structural basis for the sheddase function of human meprin beta metalloproteinase at the plasma membrane. Proc Natl Acad Sci USA 109(40):16131–16136. https://doi.org/10.1073/pnas.1211076109 · DOI
  116. Peters F, Scharfenberg F, Colmorgen C, Armbrust F, Wichert R, Arnold P, Potempa B, Potempa J, Pietrzik CU, Hasler R, Rosenstiel P, Becker-Pauly C (2019) Tethering soluble meprin alpha in an enzyme complex to the cell surface affects IBD-associated genes. FASEB J 2019:fj201802391R. https://doi.org/10.1096/fj.201802391r · DOI
  117. Seegar TCM, Killingsworth LB, Saha N, Meyer PA, Patra D, Zimmerman B, Janes PW, Rubinstein E, Nikolov DB, Skiniotis G, Kruse AC, Blacklow SC (2017) Structural Basis for Regulated Proteolysis by the alpha-Secretase ADAM10. Cell 171(7):1638–1648 e1637. https://doi.org/10.1016/j.cell.2017.11.014 · DOI
  118. Liu L, Ding L, Rovere M, Wolfe MS, Selkoe DJ (2019) A cellular complex of BACE1 and gamma-secretase sequentially generates Abeta from its full-length precursor. J Cell Biol 218(2):644–663. https://doi.org/10.1083/jcb.201806205 · DOI · Paper page

Cited by

Sorted by citations

Metadata

Authors
Scharfenberg, F., Armbrust, F., Marengo, L., Pietrzik, C., & Becker-Pauly, C.
ORCID
Becker-Pauly, Christoph
Venue
Cellular and Molecular Life Sciences
Publisher
Springer Science and Business Media LLC
Published
2019-06-14
Volume
76
Issue
16
Pages
3193-3206
ISSN
  • 1420-682X
  • 1420-9071
DOI
10.1007/s00018-019-03179-1
Cited by
29
References
5
Language
en
Licence
Funders
  • Alzheimer Forschung Initiative (18007)
  • Deutsche Forschungsgemeinschaft (125440785 A9, 125440785 A15, BE 4086/2-2)

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review